Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Birgit U. Jaki

Birgit U. Jaki


Clinical Associate Professor, College of Pharmacy - Pharmaceutical Sciences

Contact

Office Phone:

(312) 996-5232 (work)

Email:

bjaki@uic.edu

Related Sites:

Teaching and Supervision Heading link

PDAT 3: Renal/Electro/Nutrition (PHAR 503), 8/15/2022 – 12/10/2022
PDAT 9: Hematology/Oncology (PHAR 509), 1/10/2022 – 4/29/2022
PDAT 6: Infectious Diseases (PHAR 506), 1/10/2022 – 4/29/2022
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 5/6/2022
PDAT 6: Infectious Diseases (PHAR 506), 1/10/2022 – 5/6/2022
Biomedicinal Chemistry (PHAR 423), 1/10/2022 – 4/29/2022
Biomedicinal Chemistry (PHAR 423), 1/10/2022 – 4/29/2022
Biomedicinal Chemistry (PHAR 423), 1/10/2022 – 4/29/2022
PDAT 2: GI/Endocrine (PHAR 502), 1/10/2022 – 4/29/2022

Selected Grants

Center for Natural Product Technologies at UIC, National Institutes of Health (National Center for Complementary and Integrative Health)., 9/1/2015 - 6/30/2020, Obligated Amount: $1456875; Anticipated Amount: $1456875

Development of A Transformative Approach To The Rapid Detection, Isolation and Identification Of Anti-Tuberculosis Natural Products, National Institutes of Health (National Institute of Allergy and Infectious Diseases)., 2/15/2012 - 1/31/2015, Obligated Amount: $401136; Anticipated Amount: $401136

Spectrometric Validation of Botanical Materials and References Standards, National Institutes of Health (National Center for Complementary and Integrative Health)., 9/30/2009 - 9/29/2012, Obligated Amount: $1231805; Anticipated Amount: $1231805

Use Of Essential Oils For The Treatment Of Extensively Drug Resistant Tuberculosis, GCET-Korea., 12/1/2007 - 5/30/2009, Obligated Amount: $91304; Anticipated Amount: $91304

Selected Publications

Okorie-Awé, Clara, Crawford, Stephanie Y, Sharp, Lisa K, Jaki, Birgit U, Kachlic, Marlowe Djuric. (2021). A faculty and staff workshop on microaggression and implicit bias: Knowledge and awareness of student, faculty, and staff experiences. Currents in Pharmacy Teaching and Learning, 13, (9), 1200-1209. doi:10.1016/j.cptl.2021.06.031.

Jaki, Birgit U, Bzhelyansky, Anton, Pauli, Guido F. (2020). Quantitative NMR (qNMR) for pharmaceutical analysis: The pioneering work of George Hanna at the US FDA. Magnetic Resonance in Chemistry, 59, (1), 7-15. doi:10.1002/mrc.5099.

Achanta, Prabhakar S, Jaki, Birgit U, McAlpine, James B, Friesen, J Brent, Niemitz, Matthias, Chen, Shao-Nong, Pauli, Guido F. (2020). Quantum mechanical NMR full spin analysis in pharmaceutical identity testing and quality control. Journal of Pharmaceutical and Biomedical Analysis, 192, 113601. doi:10.1016/j.jpba.2020.113601.

Grzelak, Edyta M, Choules, Mary P, Gao, Wei, Cai, Geping, Wan, Baojie, Wang, Yuehong, McAlpine, James B, Cheng, Jinhua, Jin, Yingyu, Lee, Hanki, Suh, Joo-Won, Pauli, Guido F, Franzblau, Scott G, Jaki, Birgit U, Cho, Sanghyun. (2019). Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening. The Journal of Antibiotics, 72, (10), 719-728. doi:10.1038/s41429-019-0205-9.

Choules, Mary P, Wolf, Nina M, Lee, Hyun, Anderson, Jeffrey R, Grzelak, Edyta M, Wang, Yuehong, Ma, Rui, Gao, Wei, McAlpine, James B, Jin, Ying-Yu, Cheng, Jinhua, Lee, Hanki, Suh, Joo-Won, Duc, Nguyen Minh, Paik, Seungwha, Choe, Jin Ho, Jo, Eun-Kyeong, Chang, Chulhun L, Lee, Jong Seok, Jaki, Birgit U, Pauli, Guido F, Franzblau, Scott G, Cho, Sanghyun. (2019). Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus. Antimicrobial Agents and Chemotherapy, 63, (3), e02204-e02218. doi:10.1128/aac.02204-18.

Choules, Mary P, Bisson, Jonathan, Gao, Wei, Lankin, David C, McAlpine, James B, Niemitz, Matthias, Jaki, Birgit U, Franzblau, Scott G, Pauli, Guido F. (2019). Quality Control of Therapeutic Peptides by 1H NMR HiFSA Sequencing. The Journal of Organic Chemistry, 84, (6), 3055-3073. doi:10.1021/acs.joc.8b02704.

Cho, Sang Hyun, Grzelak, EM, Choules, MP, Gao, W, Cai, G, Wan, B, Yuehong, W, McAlpine, JB, Cheng, J, Jin, Y, Lee, H, Suh, J, Pauli, GF, Franzblau, SG, Jaki, BU. (2019). Strategies in Anti-Mycobacterium tuberculosis Drug Discovery based on Phenotypic Screening. Journal of Antibiotics: an international journal devoted to research on bioactive microbial products.

Cho, Sang Hyun, Choules, MP, Wolf, NM, Lee, H, Anderson, JR, Grzelak, EM, Wang, Y, Ma, R, Gao, W, McAlpine, JB, Jin, Y, Cheng, J, Lee, H, Suh, J, Duc, NM, Paik, S, Choe, JH, Jo, E, Chang, CH, Lee, JS, Jaki, BU, Pauli, GF, Franzblau, SG. (2019). Rufomycin targets ClpC1 proteolysis in Mycobacterium tuberculosis and M. abscessus.. Antimicrobial Agents and Chemotherapy.

Choules, Mary P, Klein, Larry L, Lankin, David C, McAlpine, James B, Cho, Sang-Hyun, Cheng, Jinhua, Lee, Hanki, Suh, Joo-Won, Jaki, Birgit U, Franzblau, Scott G, Pauli, Guido F. (2018). Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and Rufomycin. The Journal of Organic Chemistry, 83, (12), 6664-6672. doi:10.1021/acs.joc.8b00988.

Notable Honors

2017, Teacher of the Semester Award, University of Illinois at Chicago

2015, UIC Teaching Recognition Program, University of Illinois at Chicago

Education

Degrees:
PhD, Swiss Federal Institute of Technology, Switzerland, 2000
PharmD, Ruprecht-Karls-University, Germany, 1995